Vivozon Healthcare (082800.KQ)

Vivozon Healthcare stock price today, ATLAS forecast and fair value

Healthcare · Pharmaceuticals · KOSDAQ · South Korea

₩2,960▲ +2.07%

Prices as of Oct 27, 2026 · KRW

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

47%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Vivozon Healthcare in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Vivozon Healthcare

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Vivozon Healthcare a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between ₩2,603 and ₩3,280; in 9 out of 10, between ₩2,120 and ₩4,027. Estimated annual volatility is 65%.

Price, last 12 months (weekly close)

Key numbers

Market cap: ₩176B
Market cap (USD): $133M
52-week high: ₩6,430
52-week low: ₩2,070
Revenue (12 months): ₩59.9B
Gross margin: 32.9%
Operating margin: -37.7%
Net margin: -126.7%
Beta: 0.07

What this means

ATLAS does not publish a fair value for 082800.KQ right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks 082800.KQ has traded between ₩2,070 and ₩6,430. Today it is 54.0% below that high and 43% above its low.

Its beta is 0.07: it tends to move less than the market.

About the company

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications.

Want to see everything about Vivozon Healthcare?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Vivozon Healthcare do?

What is the chance 082800.KQ goes up next month?

47%: close to a coin flip. In half of the simulated outcomes, 082800.KQ ends the month between ₩2,603 and ₩3,280.

How big is Vivozon Healthcare and what is its P/E ratio?

Vivozon Healthcare's market capitalization is ₩176B. We do not show a P/E because it has no positive earnings to base one on.

How volatile is 082800.KQ?

ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between ₩2,603 and ₩3,280.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer